Delivery Order SPE2DB20D2104-SPE2DB25FNBQB
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Jardiance 25 mg tablets (90-count units) with a ceiling value of $14,137.08. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The contract is scheduled for ultimate completion on July 28, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Jardiance is a medication...
- The Defense Logistics Agency awarded a delivery order valued at $12,196.14 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count packages) on August 8, 2025, with an ultimate completion date of August 11, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Jardiance is a prescription medication used in diabetes management, representing...
- The Defense Logistics Agency awarded a delivery order valued at $10,287.08 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count units) on September 15, 2025, with completion scheduled for September 16, 2025. This firm fixed-price delivery order represents a non-set-aside competitive award and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Jardiance is a diabetes medication commonly used to treat type 2 diabetes and is part of the...
- The Defense Logistics Agency awarded a $6,777.88 delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Jardiance 25 mg tablets (90-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of September 10, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Jardiance is a prescription diabetes medication commonly used to...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Jardiance 25 mg tablets (90-count) with a ceiling value of $4,120.39. This is a firm fixed-price delivery order with no set-aside designation, issued under a competitive procurement process. The order is scheduled for completion by July 25, 2025, with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Jardiance is a diabetes...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Jardiance 10 mg tablets in a 90-count package. This delivery order, valued at $26,553.55, represents a firm fixed-price contract with no set-aside designation, reflecting a competitively awarded procurement. The contract is scheduled for completion by September 4, 2025, with performance to be executed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a $15,724.17 delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Jardiance 10 mg tablets in a 90-count quantity. This competitively awarded, non-set-aside contract carries a firm fixed price structure and is scheduled for completion by September 16, 2025. The order will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. Jardiance is a widely prescribed medication for managing type 2...
- The Defense Logistics Agency awarded a delivery order valued at $5,240.80 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count) on July 22, 2025, with an ultimate completion date of July 23, 2025. This firm fixed price delivery order represents a non-competitive procurement and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Jardiance is a diabetes medication commonly used in military and federal healthcare systems to...
- The Defense Logistics Agency awarded a delivery order valued at $34,808.96 to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Jardiance 25 mg tablets in a 90-count quantity. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The order is scheduled for completion by August 26, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $68,604.36 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count units) on September 12, 2025, with completion scheduled for September 15, 2025. This firm fixed-price delivery order represents a competitive award with no set-aside designation and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. Jardiance is a diabetes management medication, aligning with the...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB25FNBQBDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 25, 2025, for the supply of Jardiance 25 mg tablets (90-count units) with a contract ceiling value of $1,864.83. This is a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. The order is scheduled for completion by September 26, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Jardiance is a diabetes medication commonly used to treat type 2 diabetes and is part of the broader pharmaceutical supply chain supporting military and federal healthcare systems. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a comprehensive pharmaceutical prime vendor agreement valued at $999,999,999.00 and extending through December 2026. The prime vendor contract serves as a critical vehicle for supplying a wide range of brand-name and generic medications, vaccines, and medical supplies to support military healthcare programs globally, including the Defense Health Agency and U.S. Coast Guard. AmerisourceBergen's federal contract activity demonstrates its significant role as a major pharmaceutical distributor for federal medical procurement, with a track record of fulfilling diverse medication requirements through competitively awarded contracts.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.9k | 9/25/25 |